Evidence map›Paper›PMID 31726778›Full record

ArticleInternational journal of molecular sciences2019

Quantification of Surface GalNAc Ligands Decorating Nanostructured Lipid Carriers by UPLC-ELSD.

Laura Gauthier, Mathieu Varache, Anne-Claude Couffin, Colette Lebrun, Pascale Delangle, Christelle Gateau, Isabelle Texier

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Laura GauthierUniversité Grenoble Alpes, CEA, LETI-DTBS, F-38000 Grenoble, France.
Mathieu VaracheUniversité Grenoble Alpes, CEA, LETI-DTBS, F-38000 Grenoble, France.
Anne-Claude CouffinUniversité Grenoble Alpes, CEA, LETI-DTBS, F-38000 Grenoble, France.
Colette LebrunUniversité Grenoble Alpes, CEA, CNRS, IRIG-SyMMES, F-38000 Grenoble, France.
Pascale DelangleUniversité Grenoble Alpes, CEA, CNRS, IRIG-SyMMES, F-38000 Grenoble, France.
Christelle GateauUniversité Grenoble Alpes, CEA, CNRS, IRIG-SyMMES, F-38000 Grenoble, France.
Isabelle TexierUniversité Grenoble Alpes, CEA, LETI-DTBS, F-38000 Grenoble, France.

Funding

Agence Nationale de la Recherche ANR-15-IDEX-02Agence Nationale de la Recherche CBH-EUR-GSRégion Auvergne Rhône-Alpes Ph D grant for LG
6 · The paper itself

Abstract

Nanoparticles have been extensively studied for drug delivery and targeting to specific organs. The functionalization of the nanoparticle surface by site-specific ligands (antibodies, peptides, saccharides) can ensure efficient recognition and binding with relevant biological targets. One of the main challenges in the development of these decorated nanocarriers is the accurate quantification of the amount of ligands on the nanoparticle surface. In this study, nanostructured lipid carriers (NLC) were functionalized with N-acetyl-D-galactosamine (GalNAc) units, known to target the asialoglycoprotein receptor (ASGPR). Different molar percentages of GalNAc-functionalized surfactant (0%, 2%, 5%, and 14%) were used in the formulation. Based on ultra-high-performance liquid chromatography separation and evaporative light-scattering detection (UPLC-ELSD), an analytical method was developed to specifically quantify the amount of GalNAc units present at the NLC surface. This method allowed the accurate quantification of GalNAc surfactant and therefore gave some insights into the structural parameters of these multivalent ligand systems. Our data show that the GalNAc decorated NLC possess large numbers of ligands at their surface and suitable distances between them for efficient multivalent interaction with the ASGPR, and therefore promising liver-targeting efficiency.

Indexed as

Drug CarriersGalactosamineLipidsNanoparticlesSurface-Active AgentsDrug CarriersGalactosamineLipidsSurface-Active AgentsLigand QuantificationN-acetyl-D-galactosamine ligandNanostructured Lipid CarriersSurface Functionalization

Identifiers

PMID31726778
PMCPMC6888163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.